RecruitingNot ApplicableNCT05163301
Alcohol Research in HIV: Relapse Prevention
Alcohol Research Consortium in HIV: Relapse Prevention Arm
Sponsor
Johns Hopkins University
Enrollment
150 participants
Start Date
Mar 27, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Confirmed diagnosis of HIV
- Aged 18 years or older
- Must be enrolled in clinical care at Johns Hopkins HIV Clinic.
- In addition, meet the following alcohol use criteria:
- lifetime alcohol use disorder
- patient reported outcomes (PRO) assessment collected by the Center for AIDS Research (CFAR) Network of Clinical Systems as part of usual clinical care that show in the last 3 years: periods of no or lower risk drinking (e.g. women/men who are drinking \<11/22 drinks per week) and periods of lapse to higher levels of drinking (=\>11/22 drinks per week for women/men)
- current PRO showing alcohol abstinence or alcohol use at \<11/22 drinks per week for women/men.
Exclusion Criteria2
- Acutely suicidal, homicidal, psychotic or otherwise unable to provide informed consent
- Non-English speaking because interventions are currently available in English only
Interventions
BEHAVIORALRelapse Prevention Intervention
2 session intervention to address relapse prevention among people with HIV who have an alcohol use disorder
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05163301
Related Trials
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
NCT054190241 location
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
NCT071993352 locations
LA PrEP Impact and Cost-effectiveness (TEAMS)
NCT0577454812 locations
Incidence of Liver Disease-Related Outcomes in People With HIV
NCT069403752 locations
Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
NCT001146471 location